Reckitt unit Mead Johnson not liable in latest preterm baby formula trial, company says
02/07/2026 18:13
Reckitt unit Mead Johnson not liable in latest preterm baby formula trial, company says July 2 (Reuters) - A jury in St. Louis on Thursday rejected claims that Reckitt unit Mead Johnson's specialized formula for preterm babies was to blame for causing an infant's dangerous bowel disease, according to the company.
Nearly 1,000 similar lawsuits have been filed against Enfamil manufacturer Mead Johnson, as well as Abbott Laboratories, which makes Similac formulas.
(Reporting by Diana Novak Jones)
((diana.jones2@thomsonreuters.com; 720-206-9604))
Recent news on Reckitt Benckiser
See all newsEurope Research Roundup: Barclays, Lloyds, Natwest Group
Reckitt Benckiser Gp - Director/PDMR Shareholding
Brief: Reckitt Announces Up To $600 Million Multi-Year Investment In U.S. Operations
Media: Reckitt Benckiser Group plans to invest about $400 million more over next four years in US- WSJ
Haleon secures better shelf space at Walmart, Target in bid to boost market share